Page 12 - 中国全科医学2022-20

http://www.chinagp.net E-mail:zgqkyx@chinagp.net.cn ·2441·

hormone to distinguish Cushing's disease from pseudo-Cushing states or ［26］QIAO J T，LI J Q，ZHANG W W，et al. The usefulness of the
normal physiology［J］. J Clin Endocrinol Metab，1993，77（2）： combined high-dose dexamethasone suppression test and desmopressin
503-509. DOI：10.1210/jcem.77.2.8393887. stimulation test in establishing the source of ACTH secretion in ACTH-
［13］ALEXANDRAKI K I，KALTSAS G A，ISIDORI A M，et al. The dependent Cushing's syndrome［J］. Endocr J，2021，68（7）：
prevalence and characteristic features of cyclicity and variability in 839-848. DOI：10.1507/endocrj.EJ20-0837.
Cushing's disease［J］. Eur J Endocrinol，2009，160（6）：1011- ［27］MILJIC D，JOKSIMOVIC M，DOKNIC M，et al. ACTH and cortisol
1018. DOI：10.1530/EJE-09-0046. responses to ghrelin and desmopressin in patients with Cushing's disease
［14］CECCATO F，BOSCARO M. Cushing's syndrome：screening and and adrenal enlargement［J］. J Endocrinol Invest，2010，33（8）：
diagnosis［J］. High Blood Press Cardiovasc Prev，2016，23（3）： 526-529. DOI：10.1007/BF03346641.
209-215. DOI：10.1007/s40292-016-0153-4. ［28］VASSILIADI D A，TSAGARAKIS S. DIAGNOSIS OF ENDOCRINE
［15］LORIAUX D L. Diagnosis and differential diagnosis of Cushing's DISEASE：the role of the desmopressin test in the diagnosis and follow-
syndrome［J］. N Engl J Med，2017，376（15）：1451-1459. up of Cushing's syndrome［J］. Eur J Endocrinol，2018，178（5）：
DOI：10.1056/NEJMra1505550. R201-R214. DOI：10.1530/EJE-18-0007.
［16］BARNETT R. Cushing's syndrome［J］. Lancet，2016，388（10045）： ［29］NEWELL-PRICE J，BERTAGNA X，GROSSMAN A B，et al.
649. DOI：10.1016/S0140-6736（16）31280-6. Cushing's syndrome［J］. Lancet，2006，367（9522）：1605-
［17］BÄCKLUND N，BRATTSAND G，ISRAELSSON M，et al. Reference 1617. DOI：10.1016/S0140-6736（06）68699-6.
intervals of salivary cortisol and cortisone and their diagnostic accuracy in ［30］SHARMA S T，RAFF H，NIEMAN L K. Prolactin as a marker of
Cushing's syndrome［J］. Eur J Endocrinol，2020，182（6）：569- successful catheterization during IPSS in patients with ACTH-dependent
582. DOI：10.1530/EJE-19-0872. Cushing's syndrome［J］. J Clin Endocrinol Metab，2011，96（12）：
［18］GUO Q H，YOUNG W F，ERICKSON D，et al. Usefulness of dynamic 3687-3694. DOI：10.1210/jc.2011-2149.
MRI enhancement measures for the diagnosis of ACTH-producing ［31］VASSILIADI D A，MOURELATOS P，KRATIMENOS T，et al.
pituitary adenomas［J］. Clin Endocrinol （Oxf），2015，82（2）： Inferior petrosal sinus sampling in Cushing's syndrome：usefulness and
267-273. DOI：10.1111/cen.12475. pitfalls［J］. Endocrine，2021，73（3）：530-539. DOI：10.1007/
［19］BUCHFELDER M，NISTOR R，FAHLBUSCH R，et al. The s12020-021-02764-4.
accuracy of CT and MR evaluation of the sella Turcica for detection ［32］茅江峰，柴晓峰，刘丽萍，等 . 外周 DDAVP 兴奋试验在促肾上
of adrenocorticotropic hormone-secreting adenomas in Cushing 腺皮质激素依赖性库欣综合征鉴别诊断中的价值［J］. 中国实
disease［J］. AJNR Am J Neuroradiol，1993，14（5）：1183-1190. 用内科杂志，2014，34（10）：1000-1003.
［20］PATEL V，LIU C J，SHIROISHI M S，et al. Ultra-high field magnetic MAO J F，CHAI X F，LIU L P，et al. Desmopressin stimulation test for
resonance imaging for localization of corticotropin-secreting pituitary the differential diagnosis of ACTH dependent Cushing syndrome［J］.
adenomas［J］. Neuroradiology，2020，62（8）：1051-1054. Chinese Journal of Practical Internal Medicine，2014，34（10）：
DOI：10.1007/s00234-020-02431-x. 1000-1003.
［21］SENANAYAKE R，GILLETT D，MACFARLANE J，et al. New ［33］张微微，余叶蓉，谭惠文，等 . 精氨酸血管加压素刺激试验与大
types of localization methods for adrenocorticotropic hormone-dependent 剂量地塞米松抑制试验在库欣病与异位促肾上腺皮质激素综合
Cushing's syndrome［J］. Best Pract Res Clin Endocrinol Metab， 征诊断中的价值［J］. 中华医学杂志，2016，96（11）：845-
2021，35（1）：101513. DOI：10.1016/j.beem.2021.101513. 849. DOI：10.3760/cma.j.issn.0376-2491.2016.11.004.
［22］SHI X L，DU T T，ZHU D，et al. High-dose dexamethasone ZHANG W W，YU Y R，TAN H W，et al. Value of desmopressin
suppression test is inferior to pituitary dynamic enhanced MRI in the stimulation test and high dose dexamethasone suppression testin the
differential diagnosis of ACTH-dependent Cushing's syndrome［J］. etiologic diagnosis of ACTH dependent Cushing's syndrome［J］.
Endocrine，2022，75（2）：516-524. DOI：10.1007/s12020-021- National Medical Journal of China，2016，96（11）：845-849.
02891-y. DOI：10.3760/cma.j.issn.0376-2491.2016.11.004.
［23］TSAGARAKIS S，TSIGOS C，VASILIOU V，et al. The desmopressin ［34］HOFMAN M S，LAU W F E，HICKS R J. Somatostatin receptor
68
and combined CRH-desmopressin tests in the differential diagnosis of imaging with Ga DOTATATE PET/CT：clinical utility，normal
ACTH-dependent Cushing's syndrome：constraints imposed by the patterns，pearls，and pitfalls in interpretation［J］. Radiographics，
expression of V2 vasopressin receptors in tumors with ectopic ACTH 2015，35（2）：500-516. DOI：10.1148/rg.352140164.
secretion［J］. J Clin Endocrinol Metab，2002，87（4）：1646- ［35］DEPPEN S A，BLUME J，BOBBEY A J，et al. 68Ga-DOTATATE
111
1653. DOI：10.1210/jcem.87.4.8358. compared with In-DTPA-octreotide and conventional imaging for
［24］NEWELL-PRICE J，PERRY L，MEDBAK S，et al. A combined pulmonary and gastroenteropancreatic neuroendocrine tumors：a
test using desmopressin and corticotropin-releasing hormone in the systematic review and meta-analysis［J］. J Nucl Med，2016，57（6）：
differential diagnosis of Cushing's syndrome［J］. J Clin Endocrinol 872-878. DOI：10.2967/jnumed.115.165803.
Metab，1997，82（1）：176-181. DOI：10.1210/jcem.82.1.3674. ［36］WANNACHALEE T，TURCU A F，BANCOS I，et al. The clinical
［25］QIAO J T，LI J Q，ZHANG W W，et al. The usefulness of the impact of［68 Ga］-DOTATATE PET/CT for the diagnosis and
combined high-dose dexamethasone suppression test and desmopressin management of ectopic adrenocorticotropic hormone - secreting
stimulation test in establishing the source of ACTH secretion in ACTH- tumours［J］. Clin Endocrinol （Oxf），2019，91（2）：288-294.
dependent Cushing's syndrome［J］. Endocr J，2021，68（7）： DOI：10.1111/cen.14008.
839-848. DOI：10.1507/endocrj.EJ20-0837. ［37］SANTOS A，RESMINI E，MARTÍNEZ MOMBLÁN M A，et al.